Tuesday, March 3, 2026
Essity appoints Niklas Westin Sundberg as Chief Digital & Information Officer
Hygiene and health company Essity is reshaping its digital leadership: Niklas Westin Sundberg has been appointed Chief Digital & Information Officer (CDIO), succeeding Carl-Magnus Månsson. Månsson is leaving the company to take on a new role outside Essity.
Westin Sundberg will join the Executive Management Team. His remit includes Essity’s ongoing digital transformation and the Digital Transformation and Business Enablement function.
Background in digital strategy and security
According to Essity, Westin Sundberg brings more than 20 years of experience in digital development across international, complex organizations. His work has included business-led IT strategy, cybersecurity and AI initiatives, including at global companies such as Kuehne+Nagel and ASSA ABLOY.
Start date and reporting line
The new CDIO will take up the position on April 15, 2026 and will report directly to Essity President and CEO Ulrika Kolsrud.
Related articles
Ipsen nominates Peter Guenter to Board of Directors
Ipsen has appointed Peter Guenter to its Board of Directors effective 28 January 2026. He fills the vacancy created by Henri Beaufour’s seat.
Novo Nordisk employees elect new board representatives
Novo Nordisk employees have elected new representatives to the Board of Directors. The new term starts after the AGM on 26 March 2026.
Bavarian Nordic: Paul Chaplin to step down as CEO
Bavarian Nordic says CEO Paul Chaplin will step down for personal reasons. He will stay through 2026 or until a successor is appointed.
medac appoints Dr. Christoph Willers as Chief Scientific Officer
The medac Group appoints Dr. Christoph Willers as CSO. He will lead research, clinical development and studies, plus pipeline and portfolio management.
SynAct Pharma appoints Ann Kristin Led as CFO
SynAct Pharma has named Ann Kristin Led as CFO, effective 1 March 2026. The finance executive brings experience across life sciences, pharma and med-tech.
Xspray Pharma appoints Blake Leitch as CEO, Per Andersson to become CSO
Xspray Pharma has appointed Blake Leitch as CEO, with the start date no later than June 1, 2026. Current CEO Per Andersson will become CSO.
Fresenius extends CEO Michael Sen’s contract to 2031, appoints Pawlu to the Management Board
Fresenius extends CEO Michael Sen’s contract early, taking it through 2031. Helios executive Christian Pawlu will join the Management Board on July 1, 2026.
Roche appoints Mark Dawson to lead pRED
Roche names Mark Dawson as Head of Pharma Research and Early Development from 1 May 2026 and adds him to the Enlarged Corporate Executive Committee.